After endless months of suffering, HCPs have felt hopeless about the arrival of a COVID-19 vaccine. But now Merck has delivered a breakthrough treatment: MK-4482. With rapid viral reduction, this 5-day pill helps reduce disease progression, quarantine time, and transmission. To spread this big news, we launched a campaign focused on making HCPs feel confident about providing relief for their patients.